Biostage, Inc. (BSTG)
Biostage, Inc., a biotechnology company, engages in developing bioengineered organ implants based on its Cellframe technology.
The company's Cellframe technology comprises a biocompatible scaffold that is seeded with the recipient's own stem cells. It is developing its Cellframe technology to treat life-threatening conditions of the esophagus, bronchus, or trachea.
The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2007 and is headquartered in Holliston, Massachusetts.
84 October Hill Road
Holliston, MA 01746
|Phone||774 233 7300|
|Fiscal Year||January - December|
|Reporting Currency||US Dollars|
|Dr. William L. Fodor Ph.D.||Chief Scientific Officer|
|Peter A. Pellegrino Jr.||Interim Vice President of Finance|
|Dr. Shunfu Hu Ph.D.||Vice President of Business Development and Operations|